COVID-19 vaccin et VITT

por Pernod, G.
Publicado 2021

Recombinant activated factor VII (rFVIIa-NovoSeven(®)-NovoNordisk) treatment of bleeding complications in intensive care unit

por Bonadona, A, Pavese, P, Hamidfar, R, Pernod, G, Stouls, T, Pison, C, Letoublon, C, Barnoud, D
Publicado 2002

Proposal of the French Society of Vascular Medicine for the prevention, diagnosis and treatment of venous thromboembolic disease in outpatients with COVID-19

por Khider, L., Soudet, S., Laneelle, D., Boge, G., Bura-Rivière, A., Constans, J., Dadon, M., Desmurs-Clavel, H., Diard, A., Elias, A., Emmerich, J., Galanaud, J.-P., Giordana, P., Gracia, S., Hamade, A., Jurus, C., Le Hello, C., Long, A., Michon-Pasturel, U., Mirault, T., Miserey, G., Perez-Martin, A., Pernod, G., Quere, I., Sprynger, M., Stephan, D., Wahl, D., Zuily, S., Mahe, G., Sevestre, M.A.
Publicado 2020